Talk:Phasevarion

Feedback
Most of the sources are primary sources and not literature reviews. Many of the primary sources list Srikhanta YN as an author. Only ones listing that person as an author use the term "phaseverion", so this appears to be somewhat advocacy for the moniker.

This appears to be about Type III restriction modification systems. If you look at Srikhanta YN's publications on pubmed, you can see that the better journals use the more standard nomenclature like PMID 26867950, called "Distribution of the type III DNA methyltransferases modA, modB and modD among Neisseria meningitidis genotypes: implications for gene regulation and virulence."

So perhaps move to Type III restriction modification systems and revise to base this on refs that are literature reviews from a broader range of authors. I would not pass this now but if that were done, I would do... Jytdog (talk) 04:01, 10 September 2017 (UTC)